UA123899U - APPLICATION OF THIAZOLIUM SALTS AS AGENTS INHIBITING ACETYLHOLINESTERASE AND BUTYRYLHOLINERASE ACTIVITIES - Google Patents

APPLICATION OF THIAZOLIUM SALTS AS AGENTS INHIBITING ACETYLHOLINESTERASE AND BUTYRYLHOLINERASE ACTIVITIES

Info

Publication number
UA123899U
UA123899U UAU201709914U UAU201709914U UA123899U UA 123899 U UA123899 U UA 123899U UA U201709914 U UAU201709914 U UA U201709914U UA U201709914 U UAU201709914 U UA U201709914U UA 123899 U UA123899 U UA 123899U
Authority
UA
Ukraine
Prior art keywords
butyrylholinerase
acetylholinesterase
activities
application
agents inhibiting
Prior art date
Application number
UAU201709914U
Other languages
Ukrainian (uk)
Inventor
Алла Дмитрівна Очеретнюк
Олександр Леонідович Кобзар
Ірина Миколаївна Міщенко
Олександр Павлович Козаченко
Володимир Сергійович Броварець
Андрій Іванович Вовк
Original Assignee
Інститут Біоорганічної Хімії Та Нафтохімії Нан України
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Інститут Біоорганічної Хімії Та Нафтохімії Нан України filed Critical Інститут Біоорганічної Хімії Та Нафтохімії Нан України
Priority to UAU201709914U priority Critical patent/UA123899U/en
Publication of UA123899U publication Critical patent/UA123899U/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Застосування сполук загальної формули І та їх фармацевтично прийнятних композитів як інгібіторів ацетилхолінестерази та (або) бутирилхолінестерази при лікуванні нейродегенеративних захворювань, зокрема хвороби Альцгеймера, хвороби Паркінсона, деменції тілець Леві, а також глаукоми та міастенії.The use of compounds of General formula I and their pharmaceutically acceptable composites as inhibitors of acetylcholinesterase and (or) butyrylcholinesterase in the treatment of neurodegenerative diseases, in particular Alzheimer's disease, Parkinson's disease, dementia of Levi's calves, as well as glaucoma and myasthenia.

UAU201709914U 2017-10-13 2017-10-13 APPLICATION OF THIAZOLIUM SALTS AS AGENTS INHIBITING ACETYLHOLINESTERASE AND BUTYRYLHOLINERASE ACTIVITIES UA123899U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201709914U UA123899U (en) 2017-10-13 2017-10-13 APPLICATION OF THIAZOLIUM SALTS AS AGENTS INHIBITING ACETYLHOLINESTERASE AND BUTYRYLHOLINERASE ACTIVITIES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201709914U UA123899U (en) 2017-10-13 2017-10-13 APPLICATION OF THIAZOLIUM SALTS AS AGENTS INHIBITING ACETYLHOLINESTERASE AND BUTYRYLHOLINERASE ACTIVITIES

Publications (1)

Publication Number Publication Date
UA123899U true UA123899U (en) 2018-03-12

Family

ID=61616176

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201709914U UA123899U (en) 2017-10-13 2017-10-13 APPLICATION OF THIAZOLIUM SALTS AS AGENTS INHIBITING ACETYLHOLINESTERASE AND BUTYRYLHOLINERASE ACTIVITIES

Country Status (1)

Country Link
UA (1) UA123899U (en)

Similar Documents

Publication Publication Date Title
PH12020500265A1 (en) Indole carboxamides compounds useful as kinase inhibitors
MX2015008957A (en) Fluoro-[1,3]oxazines as bace1 inhibitors.
NI201500031A (en) METHODS TO TREAT ALZHEIMER'S DISEASE AND PHARMACEUTICAL COMPOSITIONS OF THE SAME.
MX2016014634A (en) Compounds for treating ophthalmic diseases and disorders.
GEP20186892B (en) 2-amino-3, 5, 5-trifluoro-3, 4, 5, 6-tetrahydropyridines as bace1 inhibitors for treatment of alzheimer's disease
TN2017000158A1 (en) Carbazole derivatives
GEP20196949B (en) 2-amino-6-(difluoromethyl)-5, 5-difluoro-6-phenyl-3, 4, 5, 6-tetra- hydropyridines as bace1 inhibitors
PH12015502365A1 (en) Bace1 inhibitors
MX2017006447A (en) Antifungal agents.
JO3789B1 (en) Compositions and therapeutic methods for the treatment of complement -associated diseases
PH12016502394A1 (en) 1, 3, 4-thiadiazole compounds and their use in treating cancer
MX2019010756A (en) Novel imidazo[4,5-c]quinoline derivatives as lrrk2 inhibitors.
WO2016004404A3 (en) Gls1 inhibitors for treating disease
MX2017005060A (en) Tricyclic atropisomer compounds.
WO2016004413A3 (en) Gls1 inhibitors for treating disease
PH12017501668A1 (en) Bace1 inhibitors
MX2016008968A (en) Organic compounds.
TN2017000448A1 (en) Tetrahydrofurane-fused aminohydrothiazine derivatives which are useful in the treatment of alzheimer's disease
MX2016006906A (en) 5-aryl-1-imino-1-oxo-[1,2,4]thiadiazines.
UA123899U (en) APPLICATION OF THIAZOLIUM SALTS AS AGENTS INHIBITING ACETYLHOLINESTERASE AND BUTYRYLHOLINERASE ACTIVITIES
MY183757A (en) Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases
MX2016016061A (en) 2,2,2-trifluoroethyl-thiadiazines.
UA118316C2 (en) APPLICATION OF THIAZOLIUM SALTS AS AGENTS INHIBITING ACETYLHOLINESTERASE AND BUTYRYLHOLINERASE ACTIVITIES
PL420629A1 (en) New derivatives of carbamates and their application